Product correctly added to cart.

H-ALA-ARG-LEU-ASP-VAL-ALA-SER-GLU-PHE-ARG-LYS-LYS-TRP-ASN-LYS-TRP-ALA-LEU-SER-ARG-NH2

CAS: 150238-87-2 - H-ALA-ARG-LEU-ASP-VAL-ALA-SER-GLU-PHE-ARG-LYS-LYS-TRP-ASN-LYS-TRP-ALA-LEU-SER-ARG-NH2

Formula:C112H178N36O27

  • Synonyms:
  • H-Ala-Arg-Leu-Asp-Val-Ala-Ala-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-Nh2
  • Arldvaaefrkkwnkwalsr-Nh2
  • Arldvasefrkkwnkwalsr-Nh2
  • Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-Nh2
  • Pamp
  • Pamp (1-20) Human
  • Pamp Fragment 1-20 Human
Sort by


See more categories

This search does not contain any category.

Found 5 products.

discount label

Proadrenomedullin (1-20) (human)

CAS:150238-87-2

Ref: 01-4034490

1mg343.00 €
0.5mg218.00 €
Estimated delivery in United States, on Monday 8 Apr 2024
discount label

Proadrenomedullin (1-20), human

CAS:150238-87-2

Ref: TM-TP1490

100mgTo inquire
500mgTo inquire
Estimated delivery in United States, on Thursday 11 Apr 2024
discount label

PAMP (Human)

CAS:150238-87-2

Ref: 3D-PAM-4291-V

500µg374.00 €
Estimated delivery in United States, on Tuesday 23 Apr 2024
discount label

Proadrenomedullin (1-20) (human)

CAS:150238-87-2

Ref: 3D-FP109402

1mg609.00 €
2mg979.00 €
5mg1,982.00 €
250µg240.00 €
500µg390.00 €
Estimated delivery in United States, on Friday 3 May 2024
discount label

Proadrenomedullin (1-20) (human)

CAS:150238-87-2

Ref: 3D-VAB-07852

1mg557.00 €
Estimated delivery in United States, on Wednesday 8 May 2024
Welcome to CymitQuimica!Please accept the use of cookies to have a better experience on our website.

Cookies are important for you, they influence your browsing experience, they help us to protect your privacy and allow us to proceed with the requests that you demand through this website. We use our own and third-party cookies to analyze our services. If you consent to its installation, click on "Accept", otherwise click on "Reject". You can also set your preferences by clicking "Settings". More information is available in our Cookies Policy.